Loading provider…
Loading provider…
Gynecologic Oncology Physician in Chapel Hill, NC
NPI: 1073601365Primary Practice Location
UNC HOSPITALS
101 Manning Dr, Chapel Hill, NC
Primary Employer
UNC Faculty Physicians
uncmedicalcenter.org
HQ Phone
Get MD Linda's Phone Numberphone_androidMobile
Get MD Linda's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License

American Board of Obstetrics and Gynecology
Gynecologic Oncology
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 63 | 90 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 30 | 53 |
Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial.
Authors: Siobhan Kehoe, Heidi Gray, Carol Aghajanian, Michael Carney, Michael Pearl, Lisa Landrum
Publication Date: 2017-12-16
Outpatient end of life discussions shorten hospital admissions in gynecologic oncology patients.
Authors: Victoria Bae-Jump, John Boggess, Jessica Stine, John Soper, Kemi Doll, Kenneth Kim
Journal: Gynecol Oncol
Publication Date: 2013-03-29
Enhancing Care of the Survivor of Gynecologic Cancer: Managing the Menopause and Radiation Toxicity.
Authors: Van Le, Linda, McCormack, Mary
Journal: Am Soc Clin Oncol Educ Book
Lead Sponsor: University of Oklahoma
Collaborators: Tesaro, Inc.
Intervention / Treatment: DRUG: Niraparib, DRUG: dostarlimab
Lead Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Collaborators: Genmab
Intervention / Treatment: DRUG: irinotecan, DRUG: tisotumab vedotin, DRUG: gemcitabine, DRUG: pemetrexed, DRUG: topotecan, DRUG: vinorelbine
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Pembrolizumab, RADIATION: External Beam Radiation Therapy, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, PROCEDURE: Computed Tomography, PROCEDURE: X-Ray Imaging, RADIATION: Brachytherapy